Project Grant RF1NS139183

Award Date 8/5/24
Completion Date 7/31/27
Dollars Obligated $2.4M
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $502,929 Project Grant (CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders) to The Feinstein Institutes for Medical Research. The objective of this 4-year grant, with an award date of September 1, 2024, is to evaluate the impact of the Heat Vulnerability Index (HVI) on stroke functional outcomes in individuals with Alzheimer's disease and related dementias. The HVI, developed...
This Project Grant award of $1,262,930.00, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to examine the influence of cerebral small vessel disease (CSVD) on the net clinical benefit of anticoagulation therapy in intracerebral hemorrhage (ICH) survivors with atrial fibrillation (AF). The key products and services to be delivered include:...
This $624,583 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will support research at the University of Washington to identify potential therapeutic targets for preventing ischemic stroke. The project will leverage existing plasma samples, genomic data, and electronic medical records from the Heart and Vascular Health Study to evaluate...
This $1,120,805 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders federal grant program (CFDA 93.853), will support research to investigate how prior SARS-CoV-2 infection may increase the risk of vascular contributions to cognitive impairment and dementia (VCID). The research aims to: Determine how prior SARS-CoV-2 infection influences blood-brain barrier...
This federal Project Grant award of $2,575,013 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research to predict post-stroke cognitive impairment (PSCI) using machine learning (ML) techniques applied to routine clinical and imaging data. The primary awardee, Emory University, will pursue three aims: 1) learn to predict PSCI using EHR data and...
This $4.5 million project grant from the National Institute on Aging, part of the Department of Health and Human Services, supports research under the Aging Research program (CFDA 93.866). The University of Michigan will examine racial inequities in neurological conditions like vascular contributions to cognitive impairment and dementia (VCID) and stroke. Leveraging the Reasons for Geographic and Racial Differences in Stroke study cohort of over 30,000 adults, the research aims to determine...
This Project Grant award for $2,398,590.00, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will support research to investigate the role of brain microcirculation and capillary endothelial cell energetics in the development of vascular cognitive impairment and dementia (VCID) observed in Alzheimer's disease (AD) and AD-related dementias. The...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) provides $942,492 to Rush University Medical Center to conduct research on the association between silent brain infarcts (SBIs) and cognitive outcomes in survivors of spontaneous intracerebral hemorrhage (SICH). The key objectives are to determine if SBIs in SICH patients are linked to lower...
This $672,437 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports the "Advancing Community Connections and Calculating Risk to Optimize Stroke Survivorship (ACROSS)" research project. This project aims to address disparities in stroke outcomes experienced by racially/ethnically minoritized and socioeconomically...
This $834,094 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to advance research on post-stroke cognitive impairment and dementia (PSCID). The funding will support a multi-year effort leveraging a national stroke registry and Medicare data to determine the incidence and prevalence of PSCID, identify associated risk factors, and explore potential pharmacological prevention strategies. Key aspects of the research include a patient-centered approach,...

This Project Grant award of $2,403,545 from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders federal grant program (CFDA 93.853), supports research to examine the epigenetic mechanisms linking social determinants of health (SDOH) exposures to vascular cognitive impairment and dementia (VCID) after intracerebral hemorrhage (ICH) stroke. The research, titled REACH-EPIVCID, will identify epigenetic changes associated with SDOH-induced environmental differences, VCID, and blood pressure treatment resistance in a cohort of 700 ICH survivors. This will include genome-wide genotyping of 607 participants and formal mediation analyses to test causal pathways between SDOH, epigenetics, and adverse cognitive outcomes. The project is an extension of the ongoing REACH-ICH parent study and aims to yield insights into biologically modifiable targets for preventing VCID in populations disproportionately impacted by adverse SDOH. Sub-awards support quality control, data analysis, and coordination efforts by researchers at Mass General Brigham Inc. and Wake Forest University Health Sciences.

Generated 7/1/25, 2:05 AM